STOCK TITAN

[Form 4] Envista Holdings Corporation Common stock, $0.01 par value per share Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Robert Befidi, President, Diagnostics of Envista Holdings Corp (NVST), reported a Form 4 filing showing a non-derivative disposition of 3,454 shares of common stock on 08/25/2025 at a price of $21.12 per share. The filing states these shares were withheld to satisfy tax withholding obligations related to vested restricted stock units. After the transaction, Mr. Befidi beneficially owned 45,504 shares. The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.

Robert Befidi, presidente Diagnostics di Envista Holdings Corp (NVST), ha presentato un Modulo 4 che segnala una cessione non derivativa di 3.454 azioni ordinarie il 25/08/2025 al prezzo di $21,12 per azione. Il documento indica che le azioni sono state trattenute per ottemperare agli obblighi di ritenuta fiscale relativi a restricted stock units maturate. Dopo l’operazione, il sig. Befidi deteneva beneficiariamente 45.504 azioni. Il Modulo 4 è stato firmato per procura da Heather Turner il 27/08/2025.

Robert Befidi, presidente de Diagnostics en Envista Holdings Corp (NVST), presentó un Formulario 4 que muestra una disposición no derivativa de 3.454 acciones ordinarias el 25/08/2025 a $21.12 por acción. El formulario indica que las acciones fueron retenidas para cubrir las obligaciones de retención fiscal relacionadas con unidades de acciones restringidas que se habían adquirido. Tras la transacción, el Sr. Befidi poseía beneficiariamente 45.504 acciones. El Formulario 4 fue firmado por poder por Heather Turner el 27/08/2025.

Envista Holdings Corp(NVST)의 Diagnostics 부문 사장 로버트 베피디(Robert Befidi)는 2025년 8월 25일에 보통주 3,454주에 대한 비파생 처분을 보고하는 Form 4를 제출했습니다. 주당 가격은 $21.12였습니다. 서류에 따르면 해당 주식들은 기확정된 제한 주식 단위(RSU)에 대한 세금 원천징수 의무를 충당하기 위해 원천징수되었습니다. 거래 후 베피디 씨는 혜택적 보유자(beneficial owner)로서 45,504주를 보유하고 있었습니다. Form 4는 대리권에 의해 Heather Turner가 2025년 8월 27일 서명했습니다.

Robert Befidi, président Diagnostics chez Envista Holdings Corp (NVST), a déposé un Formulaire 4 révélant une cession non dérivative de 3 454 actions ordinaires le 25/08/2025 au prix de 21,12 $ par action. Le document précise que ces actions ont été retenues pour couvrir les obligations de retenue fiscale liées à des units d'actions restreintes acquises. Après la transaction, M. Befidi détenait bénéficiairement 45 504 actions. Le Formulaire 4 a été signé par procuration par Heather Turner le 27/08/2025.

Robert Befidi, President Diagnostics bei Envista Holdings Corp (NVST), reichte ein Formular 4 ein, das eine nicht-derivative Veräußerung von 3.454 Stammaktien am 25.08.2025 zu einem Preis von $21,12 je Aktie ausweist. In der Einreichung heißt es, dass die Aktien einbehalten wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit ausgeübten Restricted Stock Units zu erfüllen. Nach der Transaktion besaß Herr Befidi wirtschaftlich 45.504 Aktien. Das Formular 4 wurde am 27.08.2025 von Heather Turner per Vollmacht unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

Routine tax-withholding disposition; modest change in insider holdings, not likely material to valuation.

The filing documents a standard withholding of 3,454 shares to cover taxes on vested RSUs at $21.12 per share. Such dispositions are administrative and reduce the reporting person’s share count to 45,504. There is no indication of open-market sales for liquidity or other strategic transfers; the action appears limited to settlement of tax obligations and is typically neutral for investors.

Compliance-focused transaction demonstrating standard insider reporting and tax withholding on equity awards.

The Form 4 clearly states the shares were withheld to satisfy tax withholding on vested stock-settled RSUs, which is a common practice in equity compensation administration. The filing was executed by a POA, reflecting procedural handling. No changes to officer role or additional transfers are reported.

Robert Befidi, presidente Diagnostics di Envista Holdings Corp (NVST), ha presentato un Modulo 4 che segnala una cessione non derivativa di 3.454 azioni ordinarie il 25/08/2025 al prezzo di $21,12 per azione. Il documento indica che le azioni sono state trattenute per ottemperare agli obblighi di ritenuta fiscale relativi a restricted stock units maturate. Dopo l’operazione, il sig. Befidi deteneva beneficiariamente 45.504 azioni. Il Modulo 4 è stato firmato per procura da Heather Turner il 27/08/2025.

Robert Befidi, presidente de Diagnostics en Envista Holdings Corp (NVST), presentó un Formulario 4 que muestra una disposición no derivativa de 3.454 acciones ordinarias el 25/08/2025 a $21.12 por acción. El formulario indica que las acciones fueron retenidas para cubrir las obligaciones de retención fiscal relacionadas con unidades de acciones restringidas que se habían adquirido. Tras la transacción, el Sr. Befidi poseía beneficiariamente 45.504 acciones. El Formulario 4 fue firmado por poder por Heather Turner el 27/08/2025.

Envista Holdings Corp(NVST)의 Diagnostics 부문 사장 로버트 베피디(Robert Befidi)는 2025년 8월 25일에 보통주 3,454주에 대한 비파생 처분을 보고하는 Form 4를 제출했습니다. 주당 가격은 $21.12였습니다. 서류에 따르면 해당 주식들은 기확정된 제한 주식 단위(RSU)에 대한 세금 원천징수 의무를 충당하기 위해 원천징수되었습니다. 거래 후 베피디 씨는 혜택적 보유자(beneficial owner)로서 45,504주를 보유하고 있었습니다. Form 4는 대리권에 의해 Heather Turner가 2025년 8월 27일 서명했습니다.

Robert Befidi, président Diagnostics chez Envista Holdings Corp (NVST), a déposé un Formulaire 4 révélant une cession non dérivative de 3 454 actions ordinaires le 25/08/2025 au prix de 21,12 $ par action. Le document précise que ces actions ont été retenues pour couvrir les obligations de retenue fiscale liées à des units d'actions restreintes acquises. Après la transaction, M. Befidi détenait bénéficiairement 45 504 actions. Le Formulaire 4 a été signé par procuration par Heather Turner le 27/08/2025.

Robert Befidi, President Diagnostics bei Envista Holdings Corp (NVST), reichte ein Formular 4 ein, das eine nicht-derivative Veräußerung von 3.454 Stammaktien am 25.08.2025 zu einem Preis von $21,12 je Aktie ausweist. In der Einreichung heißt es, dass die Aktien einbehalten wurden, um Steuerabzugsverpflichtungen im Zusammenhang mit ausgeübten Restricted Stock Units zu erfüllen. Nach der Transaktion besaß Herr Befidi wirtschaftlich 45.504 Aktien. Das Formular 4 wurde am 27.08.2025 von Heather Turner per Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Befidi Robert

(Last) (First) (Middle)
C/O ENVISTA HOLDINGS CORPORATION
200 S. KRAEMER BLVD., BLDG. E

(Street)
BREA CA 92821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Envista Holdings Corp [ NVST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Diagnostics
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 F 3,454(1) D $21.12 45,504 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.
Remarks:
/s/ Heather Turner, By POA from Robert Befidi 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Robert Befidi report on the Form 4 for NVST?

He reported a disposition of 3,454 common shares on 08/25/2025 at $21.12 per share, withheld to satisfy tax obligations.

Why were the shares disposed according to the filing?

The filing states the shares were withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled restricted stock units.

How many NVST shares does the reporting person own after the transaction?

The filing reports beneficial ownership of 45,504 shares following the transaction.

Who signed the Form 4 for Robert Befidi?

The Form 4 was signed by Heather Turner by power of attorney on 08/27/2025.

What was the price per share for the transaction?

The reported price per share was $21.12.
Envista Holdings Corp

NYSE:NVST

NVST Rankings

NVST Latest News

NVST Latest SEC Filings

NVST Stock Data

3.53B
164.65M
0.56%
119.73%
5.65%
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
BREA